CORZZ
CORZZ
Core Scientific, Inc. Tranche 2 WarrantsIncome Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $81.1M ▲ | $69.22M ▲ | $-146.66M ▲ | -180.83% ▲ | $-0.46 ▼ | $-127.46M ▼ |
| Q2-2025 | $78.63M ▼ | $31.31M ▼ | $-936.8M ▼ | -1.19K% ▼ | $-0.04 ▼ | $-634K ▲ |
| Q1-2025 | $79.53M ▼ | $50.81M ▲ | $580.69M ▲ | 730.2% ▲ | $1.44 ▲ | $-20.18M ▲ |
| Q4-2024 | $94.92M ▼ | $44.55M ▲ | $-265.54M ▲ | -279.74% ▲ | $-0.6 ▲ | $-234.88M ▲ |
| Q3-2024 | $95.35M | $41.06M | $-455.26M | -477.44% | $-1.56 | $-418.31M |
What's going well?
Revenue is growing, and the net loss is much smaller than last quarter. The company is not burdened by debt costs, and share dilution is minimal.
What's concerning?
Operating expenses are growing much faster than sales, and gross margins are shrinking. The core business is deeply unprofitable, and earnings are affected by large 'other' income, making the true performance hard to judge.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $453.44M ▼ | $2.3B ▲ | $3.42B ▲ | $-1.13B ▼ |
| Q2-2025 | $581.35M ▼ | $1.98B ▲ | $3.04B ▲ | $-1.06B ▼ |
| Q1-2025 | $697.94M ▼ | $1.63B ▲ | $1.81B ▼ | $-181.51M ▲ |
| Q4-2024 | $836.2M ▲ | $1.6B ▲ | $2.42B ▲ | $-820.18M ▼ |
| Q3-2024 | $253.02M | $921.85M | $1.65B | $-729.39M |
What's financially strong about this company?
The company owns a lot of physical assets and has no risky goodwill or intangibles. Debt is all long-term, so there’s no immediate repayment pressure.
What are the financial risks or weaknesses?
Shareholder equity is deeply negative, cash is falling fast, and the company has a history of big losses. With more debt than cash and no profits, survival is at risk if things don’t improve.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-146.66M ▲ | $131.78M ▲ | $-254.36M ▼ | $-5.32M ▲ | $-127.9M ▼ | $-122.84M ▼ |
| Q2-2025 | $-936.8M ▼ | $34M ▲ | $-119.61M ▼ | $-31.77M ▼ | $-117.38M ▲ | $-87.28M ▲ |
| Q1-2025 | $580.69M ▲ | $-40.6M ▼ | $-93.46M ▼ | $-4.2M ▼ | $-138.25M ▼ | $-129.02M ▼ |
| Q4-2024 | $-184.79M ▲ | $13.8M ▲ | $-28.8M ▲ | $598.17M ▲ | $583.18M ▲ | $-14.95M ▲ |
| Q3-2024 | $-455.26M | $5.71M | $-31.24M | $182.22M | $156.7M | $-25.34M |
What's strong about this company's cash flow?
Operating cash flow improved a lot this quarter, showing the core business can generate cash. The company is not taking on new debt or diluting shareholders with new shares.
What are the cash flow concerns?
Heavy capital spending is causing big cash burn, and the company is relying on working capital changes that may not last. With no cash returned to shareholders and a shrinking cash balance, more funding will likely be needed soon.
Q1 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Core Scientific, Inc. Tranche 2 Warrants's financial evolution and strategic trajectory over the past five years.
Core Scientific benefits from substantial physical infrastructure, strong power access, and proven expertise in running large fleets of high‑density computing hardware. It has demonstrated the ability to secure major, long‑term AI hosting contracts and to raise significant capital when needed. The pivot toward AI and high‑performance computing aligns the business with powerful secular demand trends, and its proprietary management software provides a layer of operational differentiation. Recent liquidity improvements give it some breathing room to pursue this strategy.
At the same time, the financial picture is fragile: persistent large losses, deeply negative equity, and rising debt levels point to elevated solvency risk if performance does not improve. Cash generation is inconsistent, and free cash flow is mostly negative, leaving the company reliant on external financing. Competitive and execution risks around the AI/HPC pivot are high, especially as larger and financially stronger rivals push into the same space. Legacy exposure to crypto markets and energy‑intensive operations adds further regulatory, environmental, and market volatility risks.
Overall, Core Scientific appears to be in the midst of a high‑stakes transition from a capital‑intensive, volatile mining business toward a potentially more stable but fiercely competitive AI and high‑performance computing infrastructure model. The long‑term opportunity is considerable if the company can fully utilize its sites with profitable AI/HPC contracts and bring costs under control. However, the current financial condition leaves little margin for error, and outcomes are likely to be binary over time—either a successful repositioning that stabilizes the balance sheet, or continued strain if the pivot falls short of expectations. Monitoring margin trends, debt levels, contract wins, and the evolution of the AI hosting segment will be crucial for understanding how this story develops.
About Core Scientific, Inc. Tranche 2 Warrants
https://corescientific.comCore Scientific, Inc. provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $81.1M ▲ | $69.22M ▲ | $-146.66M ▲ | -180.83% ▲ | $-0.46 ▼ | $-127.46M ▼ |
| Q2-2025 | $78.63M ▼ | $31.31M ▼ | $-936.8M ▼ | -1.19K% ▼ | $-0.04 ▼ | $-634K ▲ |
| Q1-2025 | $79.53M ▼ | $50.81M ▲ | $580.69M ▲ | 730.2% ▲ | $1.44 ▲ | $-20.18M ▲ |
| Q4-2024 | $94.92M ▼ | $44.55M ▲ | $-265.54M ▲ | -279.74% ▲ | $-0.6 ▲ | $-234.88M ▲ |
| Q3-2024 | $95.35M | $41.06M | $-455.26M | -477.44% | $-1.56 | $-418.31M |
What's going well?
Revenue is growing, and the net loss is much smaller than last quarter. The company is not burdened by debt costs, and share dilution is minimal.
What's concerning?
Operating expenses are growing much faster than sales, and gross margins are shrinking. The core business is deeply unprofitable, and earnings are affected by large 'other' income, making the true performance hard to judge.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $453.44M ▼ | $2.3B ▲ | $3.42B ▲ | $-1.13B ▼ |
| Q2-2025 | $581.35M ▼ | $1.98B ▲ | $3.04B ▲ | $-1.06B ▼ |
| Q1-2025 | $697.94M ▼ | $1.63B ▲ | $1.81B ▼ | $-181.51M ▲ |
| Q4-2024 | $836.2M ▲ | $1.6B ▲ | $2.42B ▲ | $-820.18M ▼ |
| Q3-2024 | $253.02M | $921.85M | $1.65B | $-729.39M |
What's financially strong about this company?
The company owns a lot of physical assets and has no risky goodwill or intangibles. Debt is all long-term, so there’s no immediate repayment pressure.
What are the financial risks or weaknesses?
Shareholder equity is deeply negative, cash is falling fast, and the company has a history of big losses. With more debt than cash and no profits, survival is at risk if things don’t improve.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-146.66M ▲ | $131.78M ▲ | $-254.36M ▼ | $-5.32M ▲ | $-127.9M ▼ | $-122.84M ▼ |
| Q2-2025 | $-936.8M ▼ | $34M ▲ | $-119.61M ▼ | $-31.77M ▼ | $-117.38M ▲ | $-87.28M ▲ |
| Q1-2025 | $580.69M ▲ | $-40.6M ▼ | $-93.46M ▼ | $-4.2M ▼ | $-138.25M ▼ | $-129.02M ▼ |
| Q4-2024 | $-184.79M ▲ | $13.8M ▲ | $-28.8M ▲ | $598.17M ▲ | $583.18M ▲ | $-14.95M ▲ |
| Q3-2024 | $-455.26M | $5.71M | $-31.24M | $182.22M | $156.7M | $-25.34M |
What's strong about this company's cash flow?
Operating cash flow improved a lot this quarter, showing the core business can generate cash. The company is not taking on new debt or diluting shareholders with new shares.
What are the cash flow concerns?
Heavy capital spending is causing big cash burn, and the company is relying on working capital changes that may not last. With no cash returned to shareholders and a shrinking cash balance, more funding will likely be needed soon.
Q1 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Core Scientific, Inc. Tranche 2 Warrants's financial evolution and strategic trajectory over the past five years.
Core Scientific benefits from substantial physical infrastructure, strong power access, and proven expertise in running large fleets of high‑density computing hardware. It has demonstrated the ability to secure major, long‑term AI hosting contracts and to raise significant capital when needed. The pivot toward AI and high‑performance computing aligns the business with powerful secular demand trends, and its proprietary management software provides a layer of operational differentiation. Recent liquidity improvements give it some breathing room to pursue this strategy.
At the same time, the financial picture is fragile: persistent large losses, deeply negative equity, and rising debt levels point to elevated solvency risk if performance does not improve. Cash generation is inconsistent, and free cash flow is mostly negative, leaving the company reliant on external financing. Competitive and execution risks around the AI/HPC pivot are high, especially as larger and financially stronger rivals push into the same space. Legacy exposure to crypto markets and energy‑intensive operations adds further regulatory, environmental, and market volatility risks.
Overall, Core Scientific appears to be in the midst of a high‑stakes transition from a capital‑intensive, volatile mining business toward a potentially more stable but fiercely competitive AI and high‑performance computing infrastructure model. The long‑term opportunity is considerable if the company can fully utilize its sites with profitable AI/HPC contracts and bring costs under control. However, the current financial condition leaves little margin for error, and outcomes are likely to be binary over time—either a successful repositioning that stabilizes the balance sheet, or continued strain if the pivot falls short of expectations. Monitoring margin trends, debt levels, contract wins, and the evolution of the AI hosting segment will be crucial for understanding how this story develops.

CEO
Adam Sullivan
Compensation Summary
(Year 2021)
Ratings Snapshot
Rating : C
Price Target
Institutional Ownership
TORONTO DOMINION BANK
Shares:1.49M
Value:$24.72M
GOLDMAN SACHS GROUP INC
Shares:821.15K
Value:$13.66M
FLOW TRADERS U.S. LLC
Shares:324.68K
Value:$5.4M
Summary
Showing Top 3 of 37

